OrigiMed, a China-based leading precision medicine company, and Takeda, a global biopharmaceutical company based in Japa...
Tokyo Medical and Dental University (TMDU) and Fujitsu Laboratories Limited have recently completed, in less than a day,...
Japan-based Olympus has recently announced the launch of the Olympus Procedure Kits, in partnership with US-based Ruhof ...
Japan based Toyoda Gosei has developed a urethane microfoam film for cell culture, using the knowledge of urethane mater...
Thermo-electrochemical cells newly developed by researchers at Japan's Kyushu University offer a promising route to flex...
Exploring the unique set of scenarios put into motion by the COVID-19 pandemic, researchers from Japan's Kyushu Universi...
A virtual workshop on combating illegal activity related to COVID-19 was held by Taiwan, Australia, Japan and the U.S....
Sosei Group Corporation, an international biopharmaceutical group focused on the discovery and early development of...
Olympus Corporation, based in Japan, has announced that it has acquired FH ORTHO SAS, an international orthopedic compan...
Eli Lilly Japan K.K. and Daiichi Sankyo Company have concluded an agreement on commercialization collaboration in Japan ...
Takeda Pharmaceutical has announced that it will import and distribute 50 million doses of Moderna’s COVID-19...
PHC Corporation of North America (hereafter PHCNA) has announced a new partnership with On-chip Biotechnologies (USA) Co...
Japanese firm Chugai Pharmaceutical has announced that it has entered into a license agreement for worldwide non-exclu...
Japan-based Eisai Co., Ltd. and Melbourne based Cogstate, Ltd. announced that the companies have entered into ...
Japan's Fujitsu Laboratories has announced that the company will work toward the realization of an occupat...
Casio Computer Co., Ltd. on 22 Oct 2020 announced that it will unveil its medical camera to the global market ...
The global effort to ensure equitable global access to COVID-19 vaccines received a boost with the announcement of a maj...
Pfizer Inc. and BioNTech SE on 21 Oct 2020 announced the start of a Phase 1/2 study in Japan for their BN...
